AbbVie, Inc. (ABBV)
256.34
-3.87
(-1.49%)
USD |
NYSE |
Sep 04, 16:00
256.40
+0.06
(+0.02%)
After-Hours: 20:00
AbbVie Total Return Level : 448.21 for Sept. 3, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 03, 2026 | 448.21 |
| September 02, 2026 | 450.81 |
| September 01, 2026 | 447.83 |
| August 31, 2026 | 441.68 |
| August 28, 2026 | 440.06 |
| August 27, 2026 | 444.66 |
| August 26, 2026 | 452.85 |
| August 25, 2026 | 457.82 |
| August 24, 2026 | 455.64 |
| August 21, 2026 | 456.39 |
| August 20, 2026 | 451.00 |
| August 19, 2026 | 458.13 |
| August 18, 2026 | 445.99 |
| August 17, 2026 | 431.19 |
| August 14, 2026 | 429.70 |
| August 13, 2026 | 432.04 |
| August 12, 2026 | 428.49 |
| August 11, 2026 | 430.78 |
| August 10, 2026 | 427.13 |
| August 07, 2026 | 423.80 |
| August 06, 2026 | 420.07 |
| August 05, 2026 | 424.08 |
| August 04, 2026 | 419.95 |
| August 03, 2026 | 422.19 |
| July 31, 2026 | 432.24 |
| Date | Value |
|---|---|
| July 30, 2026 | 443.39 |
| July 29, 2026 | 453.53 |
| July 28, 2026 | 453.36 |
| July 27, 2026 | 442.53 |
| July 24, 2026 | 446.75 |
| July 23, 2026 | 442.55 |
| July 22, 2026 | 436.31 |
| July 21, 2026 | 441.13 |
| July 20, 2026 | 436.45 |
| July 17, 2026 | 438.36 |
| July 16, 2026 | 438.19 |
| July 15, 2026 | 420.48 |
| July 14, 2026 | 418.67 |
| July 13, 2026 | 424.17 |
| July 10, 2026 | 424.31 |
| July 09, 2026 | 427.44 |
| July 08, 2026 | 432.28 |
| July 07, 2026 | 435.55 |
| July 06, 2026 | 435.74 |
| July 02, 2026 | 446.53 |
| July 01, 2026 | 429.41 |
| June 30, 2026 | 430.40 |
| June 29, 2026 | 434.97 |
| June 26, 2026 | 433.32 |
| June 25, 2026 | 415.86 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Biogen, Inc. | 224.51 |
| Gilead Sciences, Inc. | 220.39 |
| Regeneron Pharmaceuticals, Inc. | 851.29 |
| Amgen, Inc. | 665.04 |
| REGENXBIO, Inc. | 9.20 |